Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Ceforanide is administered parenterally. It has a longer elimination half-life than any currently available cephalosporin. Its activity is very similar to that of cefamandole, another second-generation cephalosporin antibiotic, except that... Many coliforms, including Escherichia coli, Klebsiella, Enterobacter, and Proteus, are susceptible to ceforanide, as are most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species.
- Mechanism
- Curator reviewed
The bactericidal activity of ceforanide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For the treatment of infections caused by susceptible organisms.Curator reviewed
- Formula / weight
- C20H21N7O6S2 · 519.554 g/mol (avg)
- Code names
- BL-S786
Resolves to
SLAYUXIURFNXPG-CRAIPNDOSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3CC(O)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1CN)C(O)=OWhat you can answer from here — as of September 16, 2026
Which drugs share a target with Ceforanide, and which of those have an active Phase 3 trial?